approval
saveELREXFIO (ELRANATAMAB) — FDA approval
community read0 votes
Sponsor: PFIZER INC. Form: SOLUTION. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 7
- phase 3 completionCellCarta Biosciences Inc — elranatamab (Phase III Trial Completion)Apr 27, 2026 · 160d ago
- approvalELREXFIO (ELRANATAMAB) — FDA approvalFeb 19, 2026 · 227d ago
- approvalELREXFIO (ELRANATAMAB) — FDA approvalJul 10, 2025 · 451d ago
- approvalELREXFIO (ELRANATAMAB) — FDA approvalJul 8, 2025 · 453d ago
- approvalELREXFIO (ELRANATAMAB) — FDA approvalSep 10, 2024 · 754d ago
- approvalELREXFIO (ELRANATAMAB) — FDA approvalDec 13, 2023 · 1026d ago
- approvalELREXFIO (ELRANATAMAB) — FDA approvalAug 14, 2023 · 1147d ago
same company · ±60 days · 6
- approvalCLEOCIN: CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approvalMar 26, 2026
- approvalCLEOCIN: CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approvalMar 26, 2026
- approvalclindamycin hydrochloride: CLEOCIN HYDROCHLORIDE (CLINDAMYCIN HYDROCHLORIDE) — FDA approvalMar 26, 2026
- grantUNIVERSITY OF NEBRASKA LINCOLN — The matrin3-CAR-thrombin axis in hepatic inflammation and fibrosisApr 1, 2026
- approvalrimegepant sulfate ODT: NURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalMar 16, 2026
- approvalMETHYLPREDNISOLONE — FDA approvalApr 10, 2026
comments(0)
5-min edit window · permanent after that